Using cardiac biopsies from patients with hypertrophic, dilated or ischaemic cardiomyopathies, studies have revealed an increased in early stage but suppressed overall expression of Cx43 in the end‐stage of cardiomyopathy.17, 33. This evidence concerns the gene GJA1 and cardiomyopathy.